1. I

    The First Virus.....

    An interesting video.....
  2. I

    Oxford Vaccine - Thrombosis with thrombocytopenia syndrome

    Last Tuesday I posted this as a reply to a question raised by member @saw1993. It doesn't seem to be read by anyone including probably the original poster or bumped. It was about a recent paper published by a researcher in Germany who seems to have found a link with the reported blood clotting...
  3. I

    Covid 19 - T Cells might provide us protection against the variants

    T cells are a part of our immune system that focuses on specific foreign bodies...ie. rather than attacking any antigen that comes along, the T cells wait for a specific antigen. From the day we are born the T cells start developing immunity for common pathogens and as we grow up long term...
  4. I

    Why you can't compare Covid vaccines - Vaccine efficacy

    A recent short video which might be of interest for some........
  5. I

    SA variant results in antibodies that provides broad protection

    Prof Penny Moore's (South African Research Chair, Virus-Host Dynamics - University of the Witwatersrand) research has shown that people who have been infected with the coronavirus variant responsible for 98% of SA's Covid-19 cases have antibodies that fend off all variants. This suggests...
  6. I

    Recent Ebola Outbreak - Latest findings

    One might recall that there was a recent (Mid Febrary) outbreak of Ebola in Guinea and by mid-March there were some 18 cases identified with 9 deaths. The viral samples were sent to Reference Laboratory (Institut Pasteur de Dakar) for further analysis and sequencing. The results came out earlier...
  7. I

    France reports a new "Breton" Covid variant - Not detected by standard PCR

    France reports a new variant in Brittany named "Breton" variant which goes undetected by current standard PCR tests. But they report that it's no more virulent or transmissible than the original virus. The Pastuer Institute hasn't released the full sequencing details yet, other than to mention...
  8. I

    The oldest, dateable depiction of the Buddha in human form

    The Afghans are said to be the first to have Buddha statues and give a face to Buddha. The Bimaran Casket is a small, gold reliquary which bears the earliest dateable representation of the Buddha in human form. Earlier portrays of the Buddha took the form of symbols, such as footprints, a...
  9. I

    Pfizer vaccine reduced cases by 94% in Israel

    The Pfizer BioNTech coronavirus vaccine produces as good results in the “real world” as have been previously documented in randomised trials. A case control study, which has been peer reviewed and published in the New England Journal of Medicine, compared 596 618 people who were newly...
  10. I

    Intel - From inventors of the CPU to Laughing Stock - Part 2

    For Part -1 please refer to https://elakiri.com/threads/intel-from-inventors-of-the-cpu-to-laughing-stock-part-i.1973492/
  11. I

    Moderna updates their vaccine to the South African variant

    Moderna Inc. said it has made the initial batch of doses of a new Covid-19 vaccine designed to better protect people against a new strain of the coronavirus that has shown some resistance to the company’s original vaccine. The new vaccine, code-named mRNA-1273.351, is designed to better match...
  12. I

    Oxford Vaccine - Delayed second jab offers better protection

    The two-dose vaccine developed by the University of Oxford, UK, and Astra-Zeneca could be given to more people by lengthening the interval between jabs. To test the efficacy of this strategy, Andrew Pollard at the University of Oxford and his colleagues examined clinical-trial data from more...
  13. I

    Russia reports the first cace of H5N8 in humans

    Russia said on Saturday that its scientists had detected the world's first case of transmission of the H5N8 strain of avian flu from birds to humans and had alerted the World Health Organization. The head of Russia's health watchdog Rospotrebnadzor, Anna Popova, said scientists at the Vektor...
  14. I

    Another two new variants of B.1 lineage

    Two more variants are in circulation - B.1.525 & B.1.526 B.1.525 Sub-lineage of: B.1 Earliest sequence: 2020-12-15 (England/CAMC-C769B3/2020) Most recent sequence: 2021-01-28 (England/MILK-119FD0B/2021) Countries circulating: England (28), Nigeria (7), USA (7), France (5), Canada (4), Ghana...
  15. I

    The situation we live in....

    Someone has nicely explained the irony in the present situation: :P “ Never have I seen such a mess in life. The air is pure but wearing a mask is mandatory. Roads are empty but it is impossible to go on long drive. People have clean hands but there is a ban on shaking hands...
  16. I

    Covid-19 Some recent variants of interest

    In South Africa, 16 new lineages of SARS-CoV-2 were isolated between 6 March and 26 August 2020. Most of these lineages have unique mutations that have not been identified elsewhere. B.1.1.54, B.1.1.56 and C.1 spread widely in South Africa during the first wave, comprising ~42% of all...
  17. I

    An old puzzle

    There is a street of houses with consecutive numbers between 50 and 500, Find the house number, for which, the sum of numbers on the left is equal to the sum of numbers on the right. eg: Say the house numbers are 1, 2, 3, 4 , 5, 6, 7, and 8. Then house No#6 fits this condition. (either side of...
  18. I

    Novel antibody offers pan-coronavirus protection.

    Adagio Therapeutics claims that that its ADG-2 antibody candidate offered strong potency against SARS-CoV-2, as well as a range of pre-emergent coronaviruses. In in vitro and in vivo test results published January 25, ADG2 was found to bind to all known variants of SARS-CoV-2 and a range of...
  19. I

    How a village miraculously survived the Black Death - an interesting documentary

    This is an interesting documentary on how the village of Eyam, in Derbyshire survived the Black Death. How the CCR5-Delta32 mutation is linked to HIV immunity. Also those with the Delta mutation aren't get seriously affected by Covid-19 or simply they are not infected. This is not mentioned...
  20. I

    Novavax Covid vaccine shows 89.3% efficacy in UK Phase III trials.

    Novavax announced that their NVX-CoV2373, a protein-based COVID-19 vaccine candidate, met the primary endpoint, with a vaccine efficacy of 89.3%, in its Phase 3 clinical trial conducted in the United Kingdom (UK). The study assessed efficacy during a period with high transmission and with a new...

    No contents